Epimedin B protects against bone loss and inflammation in diabetic osteoporosis rats by regulating OPG/RANKL pathway.

J Orthop Surg Res · 2025 · PMC12016483 · PMID 40264188

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In diabetes patients, approximately 50–60% show a decreasing trend in bone mineral density, and approximately 33% are diagnosed with osteoporosis [ 35 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.